Mardiza, Rosemalyn L.

HRN: 22-23-72  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2022
CEFUROXIME 500MG (TAB)
11/22/2022
11/29/2022
PO
500mg
BID X 7 Days
UTI; Pus Cells: 8-10; Bacteria: Abundant
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: